ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 349

Improving the Performance of the Spanish Version of QOL-RA

Carolina Ayelen Isnardi1, Dafne Capelusnik2, Emilce E Schneeberger3, María de los Angeles Correa4, Romina Lim5, María Hu5, María Janina Tapia6, Eduardo Mario Kerzberg7, Eliana Soledad Blanco8, Federico Lujan Benavidez8, Luciana Gonzalez Lucero9, Ana Lucia Barbaglia9, Marcela Bazzarelli10, Hernán Maldonado Ficco11, Silvana Karina Pérez12, Claudia Hartvig13, Mariana Salcedo14 and Gustavo Citera15, 1Reumatology, Instituto de Rehabilitación Psicofísica, CABA, Argentina, 2Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, 3Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Reumatology, Hospital Penna, CABA, Argentina, 6Reumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, 7Department of Rheumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, 8Reumatology, Hospital General de Agudos Dr. Cosme Argerich, CABA, Argentina, 9Hospital Angel C. Padilla, Tucuman, Argentina, 10Reumatology, Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina, 11Rheumatology Section, Hospital San Antonio de Padua, Río Cuarto- Córdoba, Argentina, 12Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, CABA, Argentina, 13Rheumatology Section, Hospital Provincial de Rosario, Rosario-Santa Fe, Argentina, 14Reumatology, San Nicolás, Buenos Aires, Argentina, 15Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: quality of life and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurements of Healthcare Quality Poster – ARHP

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We have recently validated the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA). Redundancy between questions Nº 3 and Nº 6 was observed, and it was influenced by age and disease duration. For this reason, with the author’s permission, we have changed these questions and developed a new version of Spanish QOL-RA. The aim of our study was to validate this Spanish version in patients with RA.

 

Methods: A cross-sectional multicenter study was carried out. Patients ≥18 years old, with a diagnosis of RA according to ACR-EULAR 2010 criteria were included.  Patients with difficulties in answering the questionnaire (illiterate, blind) and with decompensated comorbidities were excluded. Sociodemographic data, comorbidities, RA characteristics, disease activity current treatment were registered. Questionnaires were administered to assess quality of life by EQ-5D-3L and QOL-RA, functional capacity by HAQ-A and depression by PHQ-9. The time to complete and calculate both quality of life questionnaires was measured, and the difficulties that the patients presented to complete any item were recorded. The QOL-RA was re-administered in 20 patients to evaluate reproducibility. Statistical analysis: Student´s T, ANOVA and Chi2 tests. Spearman correlation. Reliability by Cronbach´s alpha. Reproducibility using ICC. QOL-RA linear tendency based on RA activity by multinomial logistic regression with completed factorial model. Multiple linear regression.

 

Results: 430 patients were included. 87.7% were females, with a median (m) age of 53.1 years (IQR 45-62) and m disease duration of 8.9 years (IQR 4-16). Disease activity by DAS28-ESR was m 2.9 (IQR 1.9-3.9). The median of QOL-RA was 6.6 (IQR 5.3-8) and it had a good correlation with EQ-5D-3L (Rho: 0.6), PHQ-9 (Rho: -0.56), HAQ-A (Rho: -0.55), CDAI (Rho: -0.47) and DAS28-ESR (Rho: -0.4). Worse QOL-RA was observed in current smokers (mean 6.1±1.7 vs 6.6±1.9, p= 0.016), unemployed (mean 6.1±1.8 vs 6.9±1.8, p=0.0001), patients not doing physical activity (mean 6.3±1.9 vs 7±1.9, p=0.0001) and those with morning stiffness (mean 5.8±1.9 vs 7.1 ±1.7, p=0.0001). It showed very good reliability (0.97) and reproducibility (ICC= 0.96 IC 95% 0.90-0.99). Ceiling and floor effects were 2.8% and 0.7%, respectively. Only 0.9% of the questionnaires presented at least one missing answer. There was no redundancy between questions. Patients with higher disease activity had a significant poorer quality of life. (Figure 1) In the multivariate analysis, using QOL-RA as dependent variable, adjusting by age, sex and disease duration, disability, disease activity, and the presence of depression were independently associated to worse quality of life.

 

Conclusion: This new version of QOL-RA demonstrated better construct validity, reproducibility and reliability compared to the original version and it was easy to complete and calculate.

 


Disclosure: C. A. Isnardi, None; D. Capelusnik, None; E. E. Schneeberger, None; M. D. L. A. Correa, None; R. Lim, None; M. Hu, None; M. J. Tapia, None; E. M. Kerzberg, None; E. S. Blanco, None; F. L. Benavidez, None; L. Gonzalez Lucero, None; A. L. Barbaglia, None; M. Bazzarelli, None; H. Maldonado Ficco, None; S. K. Pérez, None; C. Hartvig, None; M. Salcedo, None; G. Citera, Bristol-Myers Squibb, Pfizer, AbbVie, Roche, Eli Lilly, Genzyme, 5.

To cite this abstract in AMA style:

Isnardi CA, Capelusnik D, Schneeberger EE, Correa MDLA, Lim R, Hu M, Tapia MJ, Kerzberg EM, Blanco ES, Benavidez FL, Gonzalez Lucero L, Barbaglia AL, Bazzarelli M, Maldonado Ficco H, Pérez SK, Hartvig C, Salcedo M, Citera G. Improving the Performance of the Spanish Version of QOL-RA [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/improving-the-performance-of-the-spanish-version-of-qol-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-performance-of-the-spanish-version-of-qol-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology